Publication:
Literature review and evaluation of biomarkers, matrices and analytical methods for chemicals selected in the research program Human Biomonitoring for the European Union (HBM4EU)

dc.contributor.authorSabbioni, Gabriele
dc.contributor.authorCastaño, Argelia
dc.contributor.authorEsteban-Lopez, Marta
dc.contributor.authorGöen, Thomas
dc.contributor.authorMol, Hans
dc.contributor.authorRiou, Margaux
dc.contributor.authorTagne-Fotso, Romuald
dc.contributor.funderState Secretariat for Education, Research, and Innovation (Suiza)es_ES
dc.contributor.funderUnión Europea. Comisión Europea. H2020
dc.date.accessioned2023-04-24T09:57:21Z
dc.date.available2023-04-24T09:57:21Z
dc.date.issued2022-11
dc.description.abstractHumans are potentially exposed to a large amount of chemicals present in the environment and in the workplace. In the European Human Biomonitoring initiative (Human Biomonitoring for the European Union = HBM4EU), acrylamide, mycotoxins (aflatoxin B1, deoxynivalenol, fumonisin B1), diisocyanates (4,4'-methylenediphenyl diisocyanate, 2,4- and 2,6-toluene diisocyanate), and pyrethroids were included among the prioritized chemicals of concern for human health. For the present literature review, the analytical methods used in worldwide biomonitoring studies for these compounds were collected and presented in comprehensive tables, including the following parameter: determined biomarker, matrix, sample amount, work-up procedure, available laboratory quality assurance and quality assessment information, analytical techniques, and limit of detection. Based on the data presented in these tables, the most suitable methods were recommended. According to the paradigm of biomonitoring, the information about two different biomarkers of exposure was evaluated: a) internal dose = parent compounds and metabolites in urine and blood; and b) the biologically effective = dose measured as blood protein adducts. Urine was the preferred matrix used for deoxynivalenol, fumonisin B1, and pyrethroids (biomarkers of internal dose). Markers of the biological effective dose were determined as hemoglobin adducts for diisocyanates and acrylamide, and as serum-albumin-adducts of aflatoxin B1 and diisocyanates. The analyses and quantitation of the protein adducts in blood or the metabolites in urine were mostly performed with LC-MS/MS or GC-MS in the presence of isotope-labeled internal standards. This review also addresses the critical aspects of the application, use and selection of biomarkers. For future biomonitoring studies, a more comprehensive approach is discussed to broaden the selection of compounds.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis study was part of the HBM4EU project receiving funding from the European Union’s Horizon 2020 research and innovation program under Grant Agreement No 733032. Gabriele Sabbioni (USI) was supportedby the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number (17.00040, 733032).es_ES
dc.format.page107458es_ES
dc.format.volume169es_ES
dc.identifier.citationEnviron Int. 2022 Nov;169:107458.es_ES
dc.identifier.doi10.1016/j.envint.2022.107458es_ES
dc.identifier.e-issn1873-6750es_ES
dc.identifier.journalEnvironment internationales_ES
dc.identifier.pubmedID36179646es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15873
dc.language.isoenges_ES
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/733032/EUes_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.envint.2022es_ES
dc.repisalud.centroISCIII::Centro Nacional de Sanidad Ambientales_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHuman biomonitoringes_ES
dc.subjectPesticideses_ES
dc.subjectMycotoxinses_ES
dc.subjectAcrylamidees_ES
dc.subjectDiisocyanateses_ES
dc.subjectProtein adductses_ES
dc.subjectUrinary metaboliteses_ES
dc.subjectHBM4EUes_ES
dc.subject.meshMycotoxinses_ES
dc.subject.meshPyrethrinses_ES
dc.subject.meshAcrylamidees_ES
dc.subject.meshAflatoxin B1es_ES
dc.subject.meshAlbuminses_ES
dc.subject.meshBiological Monitoringes_ES
dc.subject.meshBiomarkerses_ES
dc.subject.meshChromatography, Liquides_ES
dc.subject.meshEuropean Uniones_ES
dc.subject.meshFumonisinses_ES
dc.subject.meshHemoglobinses_ES
dc.subject.meshHumanses_ES
dc.subject.meshTandem Mass Spectrometryes_ES
dc.subject.meshTrichotheceneses_ES
dc.titleLiterature review and evaluation of biomarkers, matrices and analytical methods for chemicals selected in the research program Human Biomonitoring for the European Union (HBM4EU)es_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication0da21b9b-e5f7-437e-b917-cebde4ae5bdd
relation.isAuthorOfPublication27208892-1792-4232-8be8-5338006f6857
relation.isAuthorOfPublication.latestForDiscovery0da21b9b-e5f7-437e-b917-cebde4ae5bdd
relation.isFunderOfPublicationa418cf3b-f427-4376-a75f-01dba9bb944f
relation.isFunderOfPublication.latestForDiscoverya418cf3b-f427-4376-a75f-01dba9bb944f
relation.isPublisherOfPublication7d471502-7bd5-4f7a-90a4-8274382509ef
relation.isPublisherOfPublication.latestForDiscovery7d471502-7bd5-4f7a-90a4-8274382509ef

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
LiteratureReviewEvaluationBiomarkers_2022.pdf
Size:
1.77 MB
Format:
Adobe Portable Document Format
Description:
Articulo
Loading...
Thumbnail Image
Name:
Supplementary_LiteratureReviewEvaluationBiomarkers_2022.pdf
Size:
786.91 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material